Epigenomics AG (FRA:ECX)
Germany · Delayed Price · Currency is EUR 0.8800
-0.0300 (-3.30%)
At close: Oct 9, 2026
Epigenomics AG Revenue
Epigenomics AG had revenue of 17.00K EUR in the half year ending June 30, 2026. This brings the company's revenue in the last twelve months to 30.00K, up 172.73% year-over-year. In the year 2025, Epigenomics AG had annual revenue of 24.00K. That makes Epigenomics AG the 46,776th largest company in the world by revenue and 643rd in Germany.
Revenue (ttm)
30.00K
Revenue Growth
+172.73%
P/S Ratio
25.72
Revenue / Employee
15.00K
Employees
3
Market Cap
771.74K
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 24.00K | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | 339.00K | -560.00K | -62.29% |
| Dec 31, 2022 | 899.00K | -5.30M | -85.51% |
| Dec 31, 2021 | 6.20M | 5.36M | 636.70% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Bayer Aktiengesellschaft | 45.38B |
| Fresenius SE & Co. KGaA | 23.28B |
| Siemens Healthineers AG | 23.17B |
| Merck KGaA | 21.14B |
| Maternus-Kliniken Aktiengesellschaft | 119.35M |
| Biofrontera AG | 15.97M |
| SynBiotic SE | 14.86M |
| Geratherm Medical AG | 13.97M |